Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Outcomes of Myelodysplastic Syndromes (MDS) Patients with Chromosome 17 Abnormalities: A Report on Behalf of the MDS Clinical Research Consortium (MDSCRC)

Rami S. Komrokji, MD, Najla Al Ali, M.Sc, John Barnard, PhD, David P. Steensma, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, David A Sallman, MD, Eric Padron, MD, Aziz Nazha, MD, Alan F List, MD, Guillermo Garcia-Manero, MD, Mikkael A. Sekeres, MD MS

Blood (2017) 130 (Supplement 1): 4246.

https://doi.org/10.1182/blood.V130.Suppl_1.4246.4246

Published: 2017

Journal Articles

The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry

Blood (2017) 130 (Supplement 1): 1701.

https://doi.org/10.1182/blood.V130.Suppl_1.1701.1701

Published: 2017

Journal Articles

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Emilia Jaskula, Andrzej Lange, MD, Mariola Sedzimirska, Jakub Chrustowicz, Agnieszka Tarnowska, Janusz Lange

Blood (2017) 130 (Supplement 1): 1420.

https://doi.org/10.1182/blood.V130.Suppl_1.1420.1420

Published: 2017

Journal Articles

Pure Erythroid Leukemia Is Characterized By TP53mutations, a Complex Karyotype with Chromosome 17 Abnormalities, and Adverse Risk Independent of Therapy Type

Guillermo Montalban-Bravo, MD, Christopher B. Benton, MD, Sa A. Wang, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Naval Daver, MD, Koichi Takahashi, MD, Courtney D DiNardo, MD, Elias J. Jabbour, MD, Gautam Borthakur, MD, Marina Konopleva, MD PhD, Sherry Pierce, BSN, BA, Keyur P. Patel, MD PhD, Steven M Kornblau, PhD, Hagop M. Kantarjian, MD, Ken H. Young, MD PhD, Guillermo Garcia-Manero, MD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 2852.

https://doi.org/10.1182/blood.V128.22.2852.2852

Published: 2016

Journal Articles

Palladin Plays an Important Role in Pulmonary Cellular Infiltration in Differentiation Syndrome

Haimin Sun, Xinlei Chen, Xin Xu, Sai-juan Chen

Blood (2014) 124 (21): 4947.

https://doi.org/10.1182/blood.V124.21.4947.4947

Published: 2014

Journal Articles

Homozygosity by descent of a 3Mb chromosome 17 haplotype causes coinheritance of Glanzmann thrombasthenia and primary ciliary dyskinesia

Giovanna D'Andrea, Michele Schiavulli, Claudia Dimatteo, Rosa Santacroce, Egidio Guerra, Vittoria A. C. Longo, Elvira Grandone, Maurizio Margaglione

Blood (2013) 122 (26): 4289–4291.

https://doi.org/10.1182/blood-2013-09-528943

Published: 2013

Journal Articles

PML/Rara and Rara/PML Chimeric Genes On Derivative Chromosome 17 In a Patient With Acute Promyelocytic Leukemia With Atypical t(15;17)(q11;q21)

Pablo Lopez, Solange Simonet, Gerardo Romanelli, Daniela Infante, Analía Sanguinetti, Victoria V Elizondo, Isabel Moro, Cecilia Canessa, Lem Martinez, M. Rosario Uriarte Escuder, PhD, Rossana Bonomi

Blood (2013) 122 (21): 4960.

https://doi.org/10.1182/blood.V122.21.4960.4960

Published: 2013

Journal Articles

ETV6-ABL1 CML Like Disorder with Complex Translocation Involving Chromosome 9, 12 and 14

Sophie Auger, MD, Jean Baptiste Gaillard, MD, Thierry Lavabre-Bertrand, PhD, Sandrine Hayette, Philippe Quittet, MD, Daniel Donadio, MD, Carole Exbrayat, MD

Blood (2012) 120 (21): 4438.

https://doi.org/10.1182/blood.V120.21.4438.4438

Published: 2012

Journal Articles

A Reappraisal of the Biological and Clinical Implications of Chromosomal Translocations in Chronic Lymphocytic Leukemia

Panagiotis Baliakas, Michalis Iskas, Anne Gardiner, Zadie Davis, Karla Plevova, Jitka Malcikova, Achilles Anagnostopoulos, Sharron Glide, Sarah Mould, Gabriela Vankova, Sarka Pospisilova, Anastasia Athanasiadou, Kostas Stamatopoulos, David Oscier

Blood (2012) 120 (21): 3915.

https://doi.org/10.1182/blood.V120.21.3915.3915

Published: 2012

Journal Articles

Prognostic Implication of Chromosome 17 Abnormalities in the Context of Monosomal Karyotype (MK) in Patients with Acute Myeloid Leukemia (AML) and Complex Cytogenetics

Aziz Nazha, Vijaya R Bhatt, MBBS, Graciela Nogueras-Gonzalez, Tapan Kadia, Jorge E. Cortes, Naval Daver, MD, Guillermo Garcia-Manero, Hagop M. Kantarjian, Gautam Borthakur

Blood (2011) 118 (21): 1495.

https://doi.org/10.1182/blood.V118.21.1495.1495

Published: 2011

Journal Articles

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL

Xavier C. Badoux, Michael J. Keating, Xuemei Wang, Susan M. O'Brien, Alessandra Ferrajoli, Stefan Faderl, Jan Burger, Charles Koller, Susan Lerner, Hagop Kantarjian, William G. Wierda

Blood (2011) 117 (11): 3016–3024.

https://doi.org/10.1182/blood-2010-08-304683

Published: 2011

Includes: Supplemental data

Journal Articles

Clinical Characterization, Prognostic Implications, and Response to Therapy In Patients with Myelodysplastic Syndrome (MDS) and Chromsome 17 Abnormality: A Single Institutional Experience

Tapan Kadia, MD, Gautam Borthakur, MD, Stefan Faderl, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Susan O'Brien, MD, Elias Jabbour, MD, Xiao Qin Dong, Sherry A. Pierce, RN, BS, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2010) 116 (21): 2930.

https://doi.org/10.1182/blood.V116.21.2930.2930

Published: 2010

Journal Articles

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hideki Makishima, MD, PhD, Anna Jankowska, MSC, Michael A McDevitt, MD, PhD, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Siddaiah Harish, MD, Mohammed Shaik, MD, Eric Hsi, MD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2010) 116 (21): 3396.

https://doi.org/10.1182/blood.V116.21.3396.3396

Published: 2010

Journal Articles

Hematopathologic Evaluation of Myelodysplastic Features of Patients with CP-CML on Therapy with Clonal Cytogenetic Abnormalities In Ph Negative Clones

Monique A Hartley, MD, Ling Zhang, MD, William Bulkeley, III, MD, Bijal D. Shah, MD, Sara Tinsley, ARNP, Javier Pinilla-Ibarz, MD

Blood (2010) 116 (21): 1224.

https://doi.org/10.1182/blood.V116.21.1224.1224

Published: 2010

Journal Articles

Clonal Evolution of Malignant Populations In Potentially Biclonal Chronic Lymphocytic Leukemia Patients

Karla Plevova, Hana Skuhrova Francova, Boris Tichy, Dr, Jitka Malcikova, Dr., Sarka Pavlova, Dr., Ondrej Horky, Olga Stehlikova, Michael Doubek, MD, PhD, Yvona Brychtova, MD, Jiri Mayer, MD, PhD, Sarka Pospisilova, Dr, PhD

Blood (2010) 116 (21): 2412.

https://doi.org/10.1182/blood.V116.21.2412.2412

Published: 2010

Journal Articles

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

Constantine S. Tam, Lynne V. Abruzzo, Katherine I. Lin, Jorge Cortes, Alice Lynn, Michael J. Keating, Deborah A. Thomas, Sherry Pierce, Hagop Kantarjian, Srdan Verstovsek

Blood (2009) 113 (18): 4171–4178.

https://doi.org/10.1182/blood-2008-09-178541

Published: 2009

Journal Articles

SNP Array-Based Analysis of Chromosome 17 Reveals Biallelic TP53 Mutations Due to Uniparental Disomy 17p in Advanced MDS and AML with Cooperating Deletions of Chromosomes 5 and 7

Monika Jasek, Lukasz P. Gondek, Nelli Bejanyan, Ramon V. Tiu, Jungwon Huh, Karl S. Theil, Christine O’ Keefe, Michael A. McDevitt, Jaroslaw P. Maciejewski

Blood (2008) 112 (11): 2521.

https://doi.org/10.1182/blood.V112.11.2521.2521

Published: 2008

Journal Articles

Chromosome 17 Abnormalities Are Associated with Worse Overall and Relapse Free Survival in Patients with Acute Myelogenous Leukemia and Poor-Risk Cytogenetics.

Gautam Borthakur, MD, Constantine Tam, Hagop Kantarjian, E. Lin, Jorge Cortes, Susan O’Brien, Charles Koller, Sherry Pierce, Michael Keating

Blood (2008) 112 (11): 1501.

https://doi.org/10.1182/blood.V112.11.1501.1501

Published: 2008

Journal Articles

Further progress in CLL therapy

Emili Montserrat

Blood (2008) 112 (4): 924–925.

https://doi.org/10.1182/blood-2008-05-155721

Published: 2008

Journal Articles

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Constantine S. Tam, Susan O'Brien, William Wierda, Hagop Kantarjian, Sijin Wen, Kim-Anh Do, Deborah A. Thomas, Jorge Cortes, Susan Lerner, Michael J. Keating

Blood (2008) 112 (4): 975–980.

https://doi.org/10.1182/blood-2008-02-140582

Published: 2008

NARROW

Outcomes of Myelodysplastic Syndromes (MDS) Patients with Chromosome 17 Abnormalities: A Report on Behalf of the MDS Clinical Research Consortium (MDSCRC)

The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Pure Erythroid Leukemia Is Characterized By TP53mutations, a Complex Karyotype with Chromosome 17 Abnormalities, and Adverse Risk Independent of Therapy Type

Palladin Plays an Important Role in Pulmonary Cellular Infiltration in Differentiation Syndrome

Homozygosity by descent of a 3Mb chromosome 17 haplotype causes coinheritance of Glanzmann thrombasthenia and primary ciliary dyskinesia

PML/Rara and Rara/PML Chimeric Genes On Derivative Chromosome 17 In a Patient With Acute Promyelocytic Leukemia With Atypical t(15;17)(q11;q21)

ETV6-ABL1 CML Like Disorder with Complex Translocation Involving Chromosome 9, 12 and 14

A Reappraisal of the Biological and Clinical Implications of Chromosomal Translocations in Chronic Lymphocytic Leukemia

Prognostic Implication of Chromosome 17 Abnormalities in the Context of Monosomal Karyotype (MK) in Patients with Acute Myeloid Leukemia (AML) and Complex Cytogenetics

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL

Clinical Characterization, Prognostic Implications, and Response to Therapy In Patients with Myelodysplastic Syndrome (MDS) and Chromsome 17 Abnormality: A Single Institutional Experience

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hematopathologic Evaluation of Myelodysplastic Features of Patients with CP-CML on Therapy with Clonal Cytogenetic Abnormalities In Ph Negative Clones

Clonal Evolution of Malignant Populations In Potentially Biclonal Chronic Lymphocytic Leukemia Patients

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

SNP Array-Based Analysis of Chromosome 17 Reveals Biallelic TP53 Mutations Due to Uniparental Disomy 17p in Advanced MDS and AML with Cooperating Deletions of Chromosomes 5 and 7

Chromosome 17 Abnormalities Are Associated with Worse Overall and Relapse Free Survival in Patients with Acute Myelogenous Leukemia and Poor-Risk Cytogenetics.

Further progress in CLL therapy

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only